| Period | 12 Dec 2013 |
|---|---|
| Event type | Conference |
| Location | BelfastShow on map |
| Degree of Recognition | International |
Related content
-
Press/Media
-
RESEARCHERS FIND KEY TO DRUG RESISTANT BOWEL CANCER
Press/Media: Research
-
Queen’s leads €6million European study to combat bowel cancer
Press/Media: Research
-
Research output
-
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)
Research output: Contribution to journal › Article › peer-review
-
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers
Research output: Contribution to journal › Article › peer-review